首页|慢性肾脏病合并耶氏肺孢子菌肺炎患者的临床及预后特征

慢性肾脏病合并耶氏肺孢子菌肺炎患者的临床及预后特征

扫码查看
目的 探讨慢性肾脏病(chronic kidney disease,CKD)合并耶氏肺孢子菌肺炎(pneumo-cystis jirovecii pneumonia,PJP)患者临床及预后特征,为该类感染诊治提供依据。方法 回顾性分析2019年10月1日至2023年10月31日南京医科大学第一附属医院病原宏基因组二代测序(metage-nomic next-generation sequencing,mNGS)检出耶氏肺孢子菌并临床诊断为PJP的CKD患者22例。根据患者的预后情况将PJP患者分为治愈组(n=14)和死亡组(n=8)。比较两组患者临床特征,实验室检查指标,疾病治疗等情况。结果 共22例CKD患者检出耶氏肺孢子菌的同时临床诊断为PJP,其中男6例(27。3%),女16例(72。7%),年龄为(57。1±16。3)岁,主要基础疾病为膜性肾病、IgA肾病、狼疮肾炎、抗中性粒细胞抗体相关性肾炎。患者发生PJP时间为肾病确诊后3(2,108)个月。16例(72。7%)患者发生Ⅰ型呼吸衰竭。所有患者在感染前3个月内使用糖皮质激素或免疫抑制剂。肺部CT主要表现为磨玻璃为主的混合型和斑片/结节型(81。8%)。所有患者乳酸脱氢酶均升高。18例(81。8%)患者(1,3)-β-葡聚糖检测阳性。16例(72。7%)患者淋巴细胞绝对值偏低。表面抗原分化簇4受体(cluster of differentiation 4 receptors,CD4)细胞计数均值为292。3个/μL,其中60。0%患者CD4细胞计数<200个/μL。入院血肌酐为(232。0±216。6)μmol/L,其中15例(68。2%)患者发生急性肾损伤,需要透析12例(54。5%)。22例患者均进行了抗PJP治疗,16例(72。7%)患者因mNGS结果调整了治疗用药。复方磺胺甲恶唑剂量为(11。0±5。8)mg·kg-1·d-1(以甲氧苄啶计)。10例(45。5%)患者需要机械通气。与治愈组相比,死亡组患者入院时口服激素剂量较大[(28。6±12。2)mg比(18。1±8。8)mg,P=0。039],需要透析(7例比5例,P=0。031)、需要机械通气(7例比3例,P=0。006)例数较多。结论 CKD患者耶氏肺孢子菌的临床感染诊断需结合临床症状、影像及实验室检查,病原mNGS可为该类感染提供病原学证据支持以辅助指导PJP的治疗。长期口服激素剂量大,需要透析、需要机械通气可能是PJP患者预后不佳的危险因素。
Characteristics and prognostic factors of chronic kidney disease patients with Pneumocystis jirovecii pneumonia
Objective To explore the clinical and prognostic characteristics of chronic kidney dis-ease(CKD)patients with Pneumocystis jirovecii pneumonia(PJP),thus facilitating the diagnosis and treatment of Pneumocystis jirovecii infections.Methods We retrospectively analyzed the clinical date of 22 CKD patients with PJP who were hospitalized in the First Affiliated Hospital with Nanjing Medical University and diagnosed by metagenomic next-generation sequencing(mNGS)from October 1,2019 to October 31,2023.Based on the prognosis,CKD patients with PJP were divided into the cured group(n=14)and death group(n=8).The clinical characteristics,laboratory examination indicators,and disease treatment situations of the two groups of patients were compared.Results A total of 22 CKD patients were diagnosed with PJP,including 6 males(27.3%)and 16 females(72.7%).The mean age was(57.1±16.3)years.The primary underlying diseases were membranous nephropathy,immunoglobulin A nephropathy(IgAN),lupus nephritis,antineutrophil cytoplasmic antibody(ANCA)-associated glo-merulonephritis.The median time of PJP was 3(2,108)months after the diagnosis of nephropathy.To-tally 16(72.7%)patients developed type Ⅰ respiratory failure.All patients had a history of glucocorti-coids or immunosuppressants use 3 months prior to PJP.CT findings included mixed ground-glass opaci-ties type and nodular type(81.8%).Lactate dehydrogenase(LDH)was elevated in all patients.The 1,3-β-glucan test was positive in 18 patients(81.8%).Lymphocyte count was low in 16 patients(72.7%).The cluster of differentiation 4 receptors(CD4)cell count averaged at 292.3 cells/μL,and 60.0%of the patients had CD4 cell count<200 cells/μL.The mean serum creatinine on admission was(232.0±216.6)μmol/L,among which 15 patients(68.2%)developed acute kidney injury and 12 patients(54.5%)required dialysis.All patients received anti-PJP therapy and 16 patients(72.7%)adjusted their medication based on mNGS results.The mean dose of compound sulfamethoxazole was(11.0±5.8)mg·kg-1·d-1(base on trimethoprim).Totally 10 patients(45.5%)required mechanical ventilation.Com-pared with the cured group,the death group had higher oral glucocorticoid dose[(28.6±12.2)mg vs(18.1±8.8)mg,P=0.039],more patients required dialysis(7 cases vs 5 cases,P=0.031),and more patients required mechanical ventilation(7 cases vs 3 cases,P=0.006).Conclusion Clinical symptoms,radiological findings,and laboratory testing should be combined to identify PJP in patients with CKD.The mNGS method is useful for etiological diagnosis of PJP and so facilitate the treatment of PJP.Long-term high-dose oral glucocorticoids,dialysis and mechanical ventilation may be risk factors for poor prog-nosis in PJP patients.

Pneumocystis jirovecii pneumoniaMetagenomic next generation sequencingNe-phrosisImmunosuppressant

刘小华、吴晶晶、曾鸣、葛益飞、张波、邬步云、毛慧娟

展开 >

南京医科大学第一附属医院药学部,南京 210029

南京医科大学第一附属医院肾内科,南京 210029

耶氏肺孢子菌肺炎 宏基因组二代测序 肾病 免疫抑制剂

2025

临床肾脏病杂志
中华医学会武汉分会,湖北省微循环学会

临床肾脏病杂志

影响因子:0.573
ISSN:1671-2390
年,卷(期):2025.25(1)